https://stock.noler.com/us/stock/ambrx-biopharma-inc https://stock.noler.com/us/stock/ambrx-biopharma-inc/13f-holdings-corporate-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/ambrx-biopharma-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/accounts-receivable https://stock.noler.com/us/stock/ambrx-biopharma-inc/accrued-liabilities-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/ambrx-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/ambrx-biopharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/amended-reports https://stock.noler.com/us/stock/ambrx-biopharma-inc/amortization https://stock.noler.com/us/stock/ambrx-biopharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/ambrx-biopharma-inc/aoci https://stock.noler.com/us/stock/ambrx-biopharma-inc/area-of-land https://stock.noler.com/us/stock/ambrx-biopharma-inc/auditor https://stock.noler.com/us/stock/ambrx-biopharma-inc/authorized-dilution https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-excluding-accrued-interest-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/ambrx-biopharma-inc/basic-shares https://stock.noler.com/us/stock/ambrx-biopharma-inc/beta https://stock.noler.com/us/stock/ambrx-biopharma-inc/borrowing-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/buybacks-repurchase-programs https://stock.noler.com/us/stock/ambrx-biopharma-inc/capital-expenditures https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-and-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/ambrx-biopharma-inc/clinical-trials https://stock.noler.com/us/stock/ambrx-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/ambrx-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/comprehensive-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/ambrx-biopharma-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/ambrx-biopharma-inc/congressional-trades https://stock.noler.com/us/stock/ambrx-biopharma-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/ambrx-biopharma-inc/contract-with-customer-receivable-after-allowance-for-credit-loss-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/ambrx-biopharma-inc/convertible-securities-outstanding https://stock.noler.com/us/stock/ambrx-biopharma-inc/convertible-securities-retired https://stock.noler.com/us/stock/ambrx-biopharma-inc/costs-and-expenses-related-party https://stock.noler.com/us/stock/ambrx-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/ambrx-biopharma-inc/current-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/ambrx-biopharma-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/ambrx-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/ambrx-biopharma-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/ambrx-biopharma-inc/customer-breakdown https://stock.noler.com/us/stock/ambrx-biopharma-inc/debt-and-obligation-disclosures https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-revenue https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-revenue-2 https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/ambrx-biopharma-inc/depreciation https://stock.noler.com/us/stock/ambrx-biopharma-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/ambrx-biopharma-inc/dividend-safety https://stock.noler.com/us/stock/ambrx-biopharma-inc/earnings-and-revenue-growth https://stock.noler.com/us/stock/ambrx-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/ambrx-biopharma-inc/ebitda https://stock.noler.com/us/stock/ambrx-biopharma-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/ambrx-biopharma-inc/effective-tax-rate https://stock.noler.com/us/stock/ambrx-biopharma-inc/eps https://stock.noler.com/us/stock/ambrx-biopharma-inc/eps-basic https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-pay-measures https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-pay-other https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-pay-pvp https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-pay-trading-arrangements https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-before-2006 https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-board https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-equity-awards https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-officers https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-other-compensation https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-other-mentions https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-pay-ratio https://stock.noler.com/us/stock/ambrx-biopharma-inc/executive-salary-relatives https://stock.noler.com/us/stock/ambrx-biopharma-inc/fails-to-deliver https://stock.noler.com/us/stock/ambrx-biopharma-inc/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/ambrx-biopharma-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/finitelived-intangible-assets-acquired https://stock.noler.com/us/stock/ambrx-biopharma-inc/foreign-currency-transaction-gain-before-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/foreign-currency-transaction-loss-before-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/free-cash-flow https://stock.noler.com/us/stock/ambrx-biopharma-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/ambrx-biopharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/gross-margin https://stock.noler.com/us/stock/ambrx-biopharma-inc/holders-breakdown https://stock.noler.com/us/stock/ambrx-biopharma-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/ambrx-biopharma-inc/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/ambrx-biopharma-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/ambrx-biopharma-inc/income-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/income-taxes-paid https://stock.noler.com/us/stock/ambrx-biopharma-inc/income-taxes-receivable https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/ambrx-biopharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-holders https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-other https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-swaps-forwards-futures https://stock.noler.com/us/stock/ambrx-biopharma-inc/insider-transactions-warrants https://stock.noler.com/us/stock/ambrx-biopharma-inc/institutional-holders https://stock.noler.com/us/stock/ambrx-biopharma-inc/intangible-assets-gross-excluding-goodwill https://stock.noler.com/us/stock/ambrx-biopharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/ambrx-biopharma-inc/interest-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/interest-income-expense-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/interest-paid-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/ambrx-biopharma-inc/investment-income-interest https://stock.noler.com/us/stock/ambrx-biopharma-inc/investment-income-interest-and-dividend https://stock.noler.com/us/stock/ambrx-biopharma-inc/investment-income-net https://stock.noler.com/us/stock/ambrx-biopharma-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/ambrx-biopharma-inc/iran-activity-notices https://stock.noler.com/us/stock/ambrx-biopharma-inc/late-filing-notices https://stock.noler.com/us/stock/ambrx-biopharma-inc/lawsuits-defendant https://stock.noler.com/us/stock/ambrx-biopharma-inc/lawsuits-plaintiff https://stock.noler.com/us/stock/ambrx-biopharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/ambrx-biopharma-inc/liabilities-assumed https://stock.noler.com/us/stock/ambrx-biopharma-inc/major-holders https://stock.noler.com/us/stock/ambrx-biopharma-inc/material-contracts https://stock.noler.com/us/stock/ambrx-biopharma-inc/mentioned-by-other https://stock.noler.com/us/stock/ambrx-biopharma-inc/minority-interest-decrease-from-redemptions https://stock.noler.com/us/stock/ambrx-biopharma-inc/mutual-fund-holders https://stock.noler.com/us/stock/ambrx-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/ambrx-biopharma-inc/net-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/net-income-loss-attributable-to-redeemable-noncontrolling-interest https://stock.noler.com/us/stock/ambrx-biopharma-inc/news https://stock.noler.com/us/stock/ambrx-biopharma-inc/obligation-breakdown https://stock.noler.com/us/stock/ambrx-biopharma-inc/oci-before-reclassifications-net-of-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/ambrx-biopharma-inc/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/oci-net-of-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-liability https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/ambrx-biopharma-inc/operating-margin https://stock.noler.com/us/stock/ambrx-biopharma-inc/other https://stock.noler.com/us/stock/ambrx-biopharma-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/other-current-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/other-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds-foreign https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds-matured https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds-matured-foreign https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds-matured-unclassified https://stock.noler.com/us/stock/ambrx-biopharma-inc/outstanding-bonds-unclassified https://stock.noler.com/us/stock/ambrx-biopharma-inc/paid-in-capital-other https://stock.noler.com/us/stock/ambrx-biopharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/ambrx-biopharma-inc/patents https://stock.noler.com/us/stock/ambrx-biopharma-inc/patents-active https://stock.noler.com/us/stock/ambrx-biopharma-inc/patents-expired https://stock.noler.com/us/stock/ambrx-biopharma-inc/patents-pending https://stock.noler.com/us/stock/ambrx-biopharma-inc/patents-rejected https://stock.noler.com/us/stock/ambrx-biopharma-inc/payables-and-obligations https://stock.noler.com/us/stock/ambrx-biopharma-inc/payments-for-rent https://stock.noler.com/us/stock/ambrx-biopharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/ambrx-biopharma-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/payments-to-minority-shareholders https://stock.noler.com/us/stock/ambrx-biopharma-inc/pb-ratio https://stock.noler.com/us/stock/ambrx-biopharma-inc/pe-ratio https://stock.noler.com/us/stock/ambrx-biopharma-inc/preferred-shares https://stock.noler.com/us/stock/ambrx-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/ambrx-biopharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/ambrx-biopharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/ambrx-biopharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/prepaid-insurance https://stock.noler.com/us/stock/ambrx-biopharma-inc/pretax-income https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/ambrx-biopharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/ambrx-biopharma-inc/profit-loss https://stock.noler.com/us/stock/ambrx-biopharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/ambrx-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/ambrx-biopharma-inc/ps-ratio https://stock.noler.com/us/stock/ambrx-biopharma-inc/public-float https://stock.noler.com/us/stock/ambrx-biopharma-inc/quick-ratio https://stock.noler.com/us/stock/ambrx-biopharma-inc/realized-investment-gains-losses https://stock.noler.com/us/stock/ambrx-biopharma-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/reddit https://stock.noler.com/us/stock/ambrx-biopharma-inc/redeemable-noncontrolling-interest-equity-carrying-amount https://stock.noler.com/us/stock/ambrx-biopharma-inc/redeemable-noncontrolling-interest-equity-redemption-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/related-party-costs https://stock.noler.com/us/stock/ambrx-biopharma-inc/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/ambrx-biopharma-inc/repayments-of-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/ambrx-biopharma-inc/research-and-development https://stock.noler.com/us/stock/ambrx-biopharma-inc/restricted-cash-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/ambrx-biopharma-inc/revenue https://stock.noler.com/us/stock/ambrx-biopharma-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/ambrx-biopharma-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/ambrx-biopharma-inc/royalty-expense https://stock.noler.com/us/stock/ambrx-biopharma-inc/sec-comment-letters https://stock.noler.com/us/stock/ambrx-biopharma-inc/sec-enforcement-actions https://stock.noler.com/us/stock/ambrx-biopharma-inc/sec-filings https://stock.noler.com/us/stock/ambrx-biopharma-inc/share-buybacks https://stock.noler.com/us/stock/ambrx-biopharma-inc/shareholder-equity https://stock.noler.com/us/stock/ambrx-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/ambrx-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/ambrx-biopharma-inc/shares-issued https://stock.noler.com/us/stock/ambrx-biopharma-inc/shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/ambrx-biopharma-inc/shares-outstanding-analysis https://stock.noler.com/us/stock/ambrx-biopharma-inc/short-interest https://stock.noler.com/us/stock/ambrx-biopharma-inc/short-sale-volume https://stock.noler.com/us/stock/ambrx-biopharma-inc/spending-and-interest-coverage https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/ambrx-biopharma-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/ambrx-biopharma-inc/subsidiaries https://stock.noler.com/us/stock/ambrx-biopharma-inc/supplier-breakdown https://stock.noler.com/us/stock/ambrx-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/ambrx-biopharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ambrx-biopharma-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/ambrx-biopharma-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/ambrx-biopharma-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/ambrx-biopharma-inc/total-assets https://stock.noler.com/us/stock/ambrx-biopharma-inc/total-contract-liability https://stock.noler.com/us/stock/ambrx-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/ambrx-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/ambrx-biopharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/ambrx-biopharma-inc/utb-change https://stock.noler.com/us/stock/ambrx-biopharma-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/ambrx-biopharma-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/ambrx-biopharma-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/ambrx-biopharma-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/ambrx-biopharma-inc/voting-outcome https://stock.noler.com/us/stock/ambrx-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/ambrx-biopharma-inc/workers-compensation-liability-current https://stock.noler.com/us/stock/ambrx-biopharma-inc/youtube